unknown
Stage
1
Investors
About
FF Pharmaceuticals develops novel disease-modifying therapeutics, focusing on clinical stage humanized anti-CD40 monoclonal antibodies for the treatment of inflammatory and autoimmune diseases.
Explore FF Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.